Genetic testing for Parkinson’s disease in clinical practice

The identification of disease-causing mutations or strong risk factors for Parkinson’s disease in genes encoding proteins such as α-synuclein (SNCA), leucine-rich repeat kinase-2 (LRRK2), or glucocerebrosidase (GBA1) has led to a better understanding of the different components of disease pathogenes...

Descripción completa

Detalles Bibliográficos
Autor principal: Gasser, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199829/
https://www.ncbi.nlm.nih.gov/pubmed/36929227
http://dx.doi.org/10.1007/s00702-023-02612-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199829/
https://www.ncbi.nlm.nih.gov/pubmed/36929227
http://dx.doi.org/10.1007/s00702-023-02612-x

Ejemplares similares